Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies [PDF]
Acta Pharmaceutica Sinica B, 2021 Amorphous solid dispersions (ASDs) are popular for enhancing the solubility and bioavailability of poorly water-soluble drugs. Various approaches have been employed to produce ASDs and novel techniques are emerging.
Sonal V. Bhujbal +8 more
doaj +4 more sources
Pre-Processing a Polymer Blend into a Polymer Alloy by KinetiSol Enables Increased Ivacaftor Amorphous Solid Dispersion Drug Loading and Dissolution [PDF]
Biomedicines, 2023 This study compares the effects of pre-processing multiple polymers together to form a single-phase polymer alloy prior to amorphous solid dispersion formulation.
Stephen A. Thompson +4 more
doaj +2 more sources
Co-Amorphous Solid Dispersion System for Improvement in Dissolution Profile of N-(((1r,4r)-4-((6-fluorobenzo[d]oxazol-2-yl)amino)cyclohexyl)methyl)-2-methylpropane-2-sulfonamide as a Neuropeptide Y5 Receptor Antagonist [PDF]
PharmaceuticsBackground/Objectives: Brick dust molecules exhibit high melting points and ultralow solubility. Overcoming this solubility issue is challenging. Previously, we formulated a co-amorphous system for a neuropeptide Y5 receptor antagonist (NP) as a brick ...
Hironori Tanaka, Hiroshi Ueda
doaj +2 more sources
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution [PDF]
Pharmaceutics, 2022 Niclosamide is an FDA-approved anthelmintic that is being studied in clinical trials as a chemotherapeutic and broad-spectrum antiviral. Additionally, several other applications are currently in the preclinical stage.
Miguel O. Jara +7 more
doaj +2 more sources
Enhancing hepatoprotective action: oxyberberine amorphous solid dispersion system targeting TLR4 [PDF]
Scientific ReportsOxyberberine (OBB) is a significant natural compound, with excellent hepatoprotective properties. However, the poor water solubility of OBB hinders its release and absorption thus resulting in low bioavailability.
Tingting Chen +7 more
doaj +2 more sources
Biopharmaceutical Study on Nobiletin-Loaded Amorphous Solid Dispersion with Improved Hypouricemic Effect [PDF]
Molecules, 2021 The present study aimed to develop an amorphous solid dispersion of nobiletin (ASD/NOB) using hydroxypropyl cellulose-SSL (HPC-SSL) to improve the pharmacokinetic properties and hypouricemic effect of NOB. ASD/NOB was prepared by the freeze-drying method
Takuya Nihei +3 more
doaj +2 more sources
Optimization of amorphous solid dispersion techniques to enhance solubility of febuxostat [PDF]
Folia Medica, 2021 Febuxostat is a selective inhibitor of xanthine oxidase and belongs to BCS class II drugs having low solubility and high permeability. Solubility is the most important parameter which directly affects dissolution, absorption and bioavailability of the ...
Vaishali P. Patel +2 more
doaj +3 more sources
Drug Design, Development and Therapy, 2020 Pei Liu,1,2 Jian-yu Zhou,2 Jin-hua Chang,2 Xi-gang Liu,2 He-fei Xue,2 Ru-xing Wang,2 Zhong-si Li,2 Chun-shi Li,3 Jian Wang,3 Cui-zhe Liu1,2 1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, People ...
Liu P +9 more
doaj +2 more sources
Ars Pharmaceutica, 2023 Introduction: Febuxostat belongs to Biopharmaceutical classification system (BCS) class II drugs, which have low solubility and high permeability. Amorphous solid dispersion is one of the techniques which can be useful to improve solubility and powder ...
Vaishali Patel, Anita Patel, Ashish Shah
doaj +1 more source
Разработка и регистрация лекарственных средств, 2023 Introduction. Ebastine is a second-generation antihistamine drug available in the form of orally disintegrating tablets and film-coated tablets. Ebastine substance exhibits high bioavailability, but low solubility in water and gastrointestinal tract ...
K. A. Gusev +7 more
doaj +1 more source